Procter & Gamble Company (The) $PG Shares Newly Purchased by Shakespeare Wealth Management LLC

Shakespeare Wealth Management LLC bought a new stake in Procter & Gamble Company (The) (NYSE:PG) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 4,443 shares of the company’s stock, valued at approximately $645,000.

A number of other institutional investors also recently modified their holdings of the company. Baxter Bros Inc. bought a new stake in shares of Procter & Gamble in the 2nd quarter worth $12,381,000. Empowered Funds LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $53,549,000. Bank of America Corp DE purchased a new position in shares of Procter & Gamble in the 2nd quarter worth about $3,850,628,000. Capstone Capital Management Ltd purchased a new position in shares of Procter & Gamble in the 3rd quarter worth about $991,000. Finally, Rokos Capital Management LLP bought a new position in Procter & Gamble during the first quarter valued at about $29,914,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Shailesh Jejurikar sold 35,000 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the sale, the chief executive officer directly owned 55,391 shares in the company, valued at approximately $9,033,718.19. The trade was a 38.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Paul Gama sold 4,331 shares of the stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $161.27, for a total value of $698,460.37. Following the sale, the chief executive officer directly owned 46,793 shares in the company, valued at $7,546,307.11. This trade represents a 8.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 58,647 shares of company stock valued at $9,268,508. 0.23% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently issued reports on PG shares. Piper Sandler raised their price objective on shares of Procter & Gamble from $145.00 to $167.00 and gave the stock a “neutral” rating in a report on Monday. The Goldman Sachs Group reiterated a “neutral” rating and issued a $161.00 target price on shares of Procter & Gamble in a research note on Thursday, October 22nd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Procter & Gamble in a research report on Friday, October 23rd. JPMorgan Chase & Co. raised their price target on shares of Procter & Gamble from $162.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday, October 23rd. Finally, TD Cowen lifted their price target on shares of Procter & Gamble from $150.00 to $166.00 and gave the stock a “hold” rating in a report on Friday, October 23rd. Fifteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $170.57.

Procter & Gamble Price Performance

PG opened at $160.48 on Friday. The firm has a 50-day moving average price of $149.62 and a 200-day moving average price of $148.85. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $371.95 billion, a price-to-earnings ratio of 24.17, a PEG ratio of 3.89 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. The company had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. Procter & Gamble’s revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.99 EPS. Equities analysts expect that Procter & Gamble Company will post 6.99 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio is currently 65.51%.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly beat supports the stock: P&G reported earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion exceeded expectations. Sales increased 4% year over year, helping reinforce confidence in the company’s growth outlook. What Did Procter & Gamble’s Latest Quarter Change for Its Stock?
• Positive Sentiment: Analyst upgrade adds support: Freedom Broker raised its rating on PG from “hold” to “buy,” signaling increased confidence in the company’s earnings durability and valuation potential. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Revenue growth and dividend appeal remain key attractions: Organic sales rose 4%, with much of the gain coming from higher product volumes. P&G’s portfolio of leading brands and long dividend history continue to appeal to income-focused investors. Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
• Neutral Sentiment: New bond issuance highlights financing strategy: P&G tapped euro and dollar markets with fixed-rate notes, providing funding flexibility but also adding debt obligations. The issuance puts greater focus on the company’s balance sheet and already elevated valuation. Procter & Gamble Bond Sale Puts Its Pricey Valuation Narrative In Focus
• Negative Sentiment: Cost inflation and mixed ratings temper optimism: Rising commodity and operating costs could pressure margins, while DZ Bank downgraded PG from “strong-buy” to “hold.” ETF net selling also represents a modest technical headwind. How Is Procter & Gamble Handling Commodity Costs After Its Report?

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.